These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


206 related items for PubMed ID: 4949244

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [NK cells--their role and importance in antitumor resistance].
    Mircheva Zh.
    Eksp Med Morfol; 1984; 23(2):99-104. PubMed ID: 6205848
    [No Abstract] [Full Text] [Related]

  • 23. Xenogeneic DNA immunization in melanoma models for minimal residual disease.
    Hawkins WG, Gold JS, Blachere NE, Bowne WB, Hoos A, Lewis JJ, Houghton AN.
    J Surg Res; 2002 Feb; 102(2):137-43. PubMed ID: 11796010
    [Abstract] [Full Text] [Related]

  • 24. [Further data on immunology in cancer].
    Gociu M.
    Stud Cercet Med Interna; 1965 Feb; 6(4):353-62. PubMed ID: 5324532
    [No Abstract] [Full Text] [Related]

  • 25. [Rearrangements in cell populations in malignant growth].
    Shuklinov VA.
    Eksp Onkol; 1984 Feb; 6(6):25-30. PubMed ID: 6396066
    [Abstract] [Full Text] [Related]

  • 26. [Aspects of immunotherapy in malignant tumors].
    Gericke D.
    Med Klin; 1968 Jul 19; 63(29):1143-6. PubMed ID: 4976478
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Concomitant tumor immunity and the resistance to a second tumor challenge.
    Gorelik E.
    Adv Cancer Res; 1983 Jul 19; 39():71-120. PubMed ID: 6194674
    [No Abstract] [Full Text] [Related]

  • 30. Dependence of immunity to Ib leukemia on an adjuvant effect of immunizing cell preparations.
    Lin JS, Murphy WH.
    Cancer Res; 1969 Dec 19; 29(12):2163-8. PubMed ID: 5369674
    [No Abstract] [Full Text] [Related]

  • 31. [Cancer therapy and the immune response of the body].
    Bergol'ts VM.
    Vopr Onkol; 1970 Dec 19; 16(12):82-93. PubMed ID: 4932064
    [No Abstract] [Full Text] [Related]

  • 32. [Carcinogenesis and immunosuppression].
    Schmähl D.
    Dtsch Med Wochenschr; 1971 Nov 05; 96(45):1771-2. PubMed ID: 4942320
    [No Abstract] [Full Text] [Related]

  • 33. Cancer of the kidney: diagnostic, therapeutic, and experimental vistas. The Percy T. Magan Memorial Lecture 1973.
    Kaufman JJ.
    Med Arts Sci; 1973 Nov 05; 27(3):28-38. PubMed ID: 4594800
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Immunotherapy in anticancer responses.
    Whelan M.
    Curr Opin Mol Ther; 2004 Feb 05; 6(1):8-9. PubMed ID: 15011775
    [No Abstract] [Full Text] [Related]

  • 36. Immunity to malignant disease in man.
    Fairley GH.
    Sci Basis Med Annu Rev; 1971 Feb 05; ():17-38. PubMed ID: 4933915
    [No Abstract] [Full Text] [Related]

  • 37. Some biologic, immunogenic, and morphologic effects in mice after infection with a murine sarcoma virus. I. Biologic and immunogenic studies.
    Law LW, Ting RC, Stanton MF.
    J Natl Cancer Inst; 1968 May 05; 40(5):1101-12. PubMed ID: 5648135
    [No Abstract] [Full Text] [Related]

  • 38. Immunology and cancer.
    Rapp HJ.
    Proc Natl Cancer Conf; 1970 May 05; 6():39-43. PubMed ID: 4318726
    [No Abstract] [Full Text] [Related]

  • 39. [Specific neoplastic antigens].
    Dux K.
    Pol Arch Med Wewn; 1970 May 05; 45(6):745-53. PubMed ID: 5505267
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.